SC CTSI is leading COVID-19 vaccine-related clinical research, education and community engaged collaborative efforts. Click here to learn more about our work.
During this 60-minute forum we discuss how the last decade has seen a revolution in research involving human participants; return of research results and incidental or secondary findings (RoR) is now routinely considered. This session addresses the current state of this transformation, ongoing debates, and the central role of RoR in translational science.
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.